BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28001021)

  • 1. Outcomes of first IVF/ICSI in young women with diminished ovarian reserve.
    Cohen J; Mounsambote L; Prier P; Mathieu d'ARGENT E; Selleret L; Chabbert-Buffet N; Delarouziere V; Levy R; Darai E; Antoine JM
    Minerva Ginecol; 2017 Aug; 69(4):315-321. PubMed ID: 28001021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
    Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
    Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
    J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis.
    Hamdan M; Dunselman G; Li TC; Cheong Y
    Hum Reprod Update; 2015; 21(6):809-25. PubMed ID: 26168799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilaterality of ovarian endometriomas does not affect the outcome of in vitro fertilization/intracytoplasmic sperm injection in infertile women after laparoscopic cystectomy.
    Yu HT; Huang HY; Tseng HJ; Wang CJ; Lee CL; Soong YK
    Biomed J; 2017 Oct; 40(5):295-299. PubMed ID: 29179885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of AMH on IVF success.
    Gomez R; Schorsch M; Hahn T; Henke A; Hoffmann I; Seufert R; Skala C
    Arch Gynecol Obstet; 2016 Mar; 293(3):667-73. PubMed ID: 26449238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sperm DNA fragmentation on the clinical outcomes for in vitro fertilization and intracytoplasmic sperm injection in women with different ovarian reserves.
    Jin J; Pan C; Fei Q; Ni W; Yang X; Zhang L; Huang X
    Fertil Steril; 2015 Apr; 103(4):910-6. PubMed ID: 25747135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.
    Moolenaar LM; Mohiuddin S; Munro Davie M; Merrilees MA; Broekmans FJ; Mol BW; Johnson NP
    Reprod Biomed Online; 2013 Oct; 27(4):362-6. PubMed ID: 23953583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of recombinant FSH dose adjustments on ovarian response in the second treatment cycle with IVF or ICSI in "standard" patients treated with 150 IU/day during the first cycle.
    Popovic-Todorovic B; Loft A; Ziebe S; Andersen AN
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):842-9. PubMed ID: 15315596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Thyroid Autoimmunity on Ovarian Reserve, Pregnancy Outcomes, and Offspring Health in Euthyroid Women Following
    Ke H; Hu J; Zhao L; Ding L; Jiao X; Qin Y
    Thyroid; 2020 Apr; 30(4):588-597. PubMed ID: 31928166
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of different typologies of smoking on ovarian reserve and oocyte quality in women performing ICSI cycles: an observational prospective study.
    Galanti F; Licata E; Paciotti G; Gallo M; Riccio S; Miriello D; Dal Lago A; Meneghini C; Fabiani C; Antonaci D; Schiavi MC; Scudo M; Salacone P; Sebastianelli A; Battaglia FA; Rago R
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5190-5199. PubMed ID: 37318508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
    Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
    Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.